EMA agency scrutinizing Avastin for breast cancer

The European Medicines Agency's CHMP began reviewing the benefit-risk profile of Avastin bevacizumab from Roche (SIX:ROG; OTCQX:RHHBY) after the company submitted data to support Avastin's expanded us...